Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Miki

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
BMC Pulmonary Medicine|June 14, 2013
Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatmentKeisuke Miki, Ryoji Maekura, Noritoshi Nagaya, et al.
The Journal of Medical Investigation : JMI|April 5, 2016
Changes in foot function, disease activity, and disability after forefoot resection arthroplasty in patients with rheumatoid arthritisFusakazu Sawachika, Hirokazu Uemura, Sakurako Katsuura-Kamano, et al.
Journal of Bacteriology|October 30, 2012
Whole-genome sequence of the hypervirulent clinical strain Mycobacterium intracellulare M.i.198Yoshitaka Tateishi, Seigo Kitada, Keisuke Miki, et al.
Journal of Breath Research|January 12, 2018
Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary diseaseKeisuke Miki, Kazuyuki Tsujino, Ryuya Edahiro, et al.
Journal of Clinical Medicine|May 7, 2020
Long-Term Treatment Outcome of Progressive <i>Mycobacterium Avium</i> Complex Pulmonary DiseaseKiyoharu Fukushima, Seigo Kitada, Yuko Abe, et al.
Thorax|September 11, 2023
Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trialKeisuke Miki, Kazuyuki Tsujino, Motonari Fukui, et al.
The Journal of Physiological Sciences : JPS|October 10, 2019
A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary diseaseKeisuke Miki, Seigo Kitada, Mari Miki, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 25, 2017
Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanismsKeisuke Miki, Ryoji Maekura, Seigo Kitada, et al.
Internal Medicine (Tokyo, Japan)|March 16, 2025
Exercise-induced Right-to-left Shunt in a Patient with Combined Pulmonary Fibrosis and EmphysemaYasuhiro Mihashi, Keisuke Miki, Hiromi Yanagi, et al.
Respiratory Medicine|August 29, 2021
Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatmentKiyoharu Fukushima, Seigo Kitada, Yuki Matsumoto, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
BMC Pulmonary Medicine|June 14, 2013
Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatmentKeisuke Miki, Ryoji Maekura, Noritoshi Nagaya, et al.
The Journal of Medical Investigation : JMI|April 5, 2016
Changes in foot function, disease activity, and disability after forefoot resection arthroplasty in patients with rheumatoid arthritisFusakazu Sawachika, Hirokazu Uemura, Sakurako Katsuura-Kamano, et al.
Journal of Bacteriology|October 30, 2012
Whole-genome sequence of the hypervirulent clinical strain Mycobacterium intracellulare M.i.198Yoshitaka Tateishi, Seigo Kitada, Keisuke Miki, et al.
Journal of Breath Research|January 12, 2018
Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary diseaseKeisuke Miki, Kazuyuki Tsujino, Ryuya Edahiro, et al.
Journal of Clinical Medicine|May 7, 2020
Long-Term Treatment Outcome of Progressive <i>Mycobacterium Avium</i> Complex Pulmonary DiseaseKiyoharu Fukushima, Seigo Kitada, Yuko Abe, et al.
Thorax|September 11, 2023
Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trialKeisuke Miki, Kazuyuki Tsujino, Motonari Fukui, et al.
The Journal of Physiological Sciences : JPS|October 10, 2019
A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary diseaseKeisuke Miki, Seigo Kitada, Mari Miki, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 25, 2017
Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanismsKeisuke Miki, Ryoji Maekura, Seigo Kitada, et al.
Internal Medicine (Tokyo, Japan)|March 16, 2025
Exercise-induced Right-to-left Shunt in a Patient with Combined Pulmonary Fibrosis and EmphysemaYasuhiro Mihashi, Keisuke Miki, Hiromi Yanagi, et al.
Respiratory Medicine|August 29, 2021
Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatmentKiyoharu Fukushima, Seigo Kitada, Yuki Matsumoto, et al.
Pageof 9